Blood Chemistry Analyzer 59th Medical Wing
Closed Special Notice Posted
- Solicitation number
- PANDHA-25-P-0000
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Jbsa Lackland, Texas 78236, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency (DHA) published this Special Notice on March 5, 2026, announcing the intent to award a sole source contract to WERFEN USA LLC for the lease of two Blood Chemistry Analyzers at the 59th Medical Wing. The contract is classified under the In-Vitro Diagnostic Substance Manufacturing category (NAICS 325413) and falls within the In Vitro Diagnostic Substances, Reagents, Test Kits and Sets PSC code. This is a non-competitive procurement, meaning no set-aside provisions are being used. The notice informs potential competitors of the Government's intent to proceed with a single vendor award, providing an opportunity for the public to submit comments or challenges during a specified period.
The Defense Health Agency requires two blood chemistry analyzers specifically capable of performing a comprehensive and integrated test menu on a single platform, including specialized assays such as antibody screening, infectious disease testing (HIV, Hepatitis B and C, CMV), and nucleic acid testing (NAT). The Government has determined that only the WERFEN NEO Iris system meets all minimum requirements due to its unique integration of this specific combination of FDA-approved tests, along with the ability to process both plasma and whole blood samples. Interested parties must submit any objections or requests for reconsideration by the March 20, 2026 deadline. The justification emphasizes that alternative solutions requiring separate platforms would create operational inefficiencies, increased staffing demands, and integration challenges with the laboratory's existing systems, making Werfen's integrated solution essential for meeting the high-throughput testing demands of the Basic Military Training mission at the 59th MDW.
Notice text
This notice is to advise the public of the intent of Defense Health Agency HCD-S to award a sole source contract to the contractor identified below.
WERFEN USA LLC (Werfen)
180 HARTWELL RD
BEDFORD MA 01730-2443
Description of Requirement:
Defense Health Agency HCD-S has a requirement for two (2) Blood Chemistry Analyzers (lease).
Justification for Sole Source Procurement:
The nature of this acquisition is highly specialized. The combination of technical specifications, physical constraints, and interoperability requirements creates a unique need that can only be met by one vendor, Werfen , with their NEO Iris system. No other known system can meet all of the Government's minimum requirements as detailed below:
Proprietary & Integrated Test Menu: The Government requires a comprehensive and specific panel of tests to be performed on a single platform, including highly specialized Antibody Screen, ABO/Rh, Antibody Titration, Antibody identification, Syphilis, Cytomegalovirus, HIV/HBV/HCV by Nucleic acid testing, WNV, Babesia, Hepatitis B Surface Antigen (HBsAg),Hepatitis B core Antibody (HBcAb), Hepatitis C Antibody (HCV Ab), Human Immunodeficiency virus types 1 and 2 antibody (HIV ½ ab), Human T Lymphotrophic virus types 1 and 2 antibody (HTLV ½ Ab), Chagas. The machine must also be able to test plasma and whole blood.
Market research indicates that only the Werden NEO Iris system integrates this exact combination of assays, including the critical, FDA-approved NAT tests, onto a single automated platform. Other vendors offer these tests on separate platforms, which would require additional space, increased staffing, workflow inefficiencies, and present significant integration challenges with our Laboratory Information System (LIS). This single, integrated platform is essential to meet the high-throughput demands of the Basic Military Training mission.
Unique Physical and Infrastructure Requirements: The laboratory space at the 59th MDW has strict and unalterable infrastructure limitations. The required analyzer must operate without an onsite water source or a floor drainage system and must not exceed the physical dimensions of 86.6” W x 35.4” D x 73.2” H. The NEO Iris analyzer is specifically designed to operate with self-contained fluidics and waste management, eliminating the need for external plumbing. This design feature, combined with its specific physical footprint, makes it the only system capable of being installed and operated in the designated space without costly and mission-disrupting facility modifications.
Advanced Sample Integrity and Handling: The SOW mandates a system with a unique combination of sample handling capabilities critical for the pediatric and low-volume samples common in a military trainee population. This includes clot, bubble, and short sample detection, automatic reflex dilution and repeat testing, and the ability to preserve pediatric samples upon aspiration error. The Werfen NEO Iris system utilizes a proprietary dual-arm pipettor with advanced liquid level sensing and clog detection that is uniquely capable of meeting all these requirements simultaneously, ensuring sample integrity and minimizing the need for painful and time-consuming redraws from trainees.
Interoperability with Existing Systems: The analyzer must establish a bi-directional interface with the hospital's Electronic Health Record (EHR) and Laboratory Information System (LIS). The NEO Iris system has a proven and validated interface that is currently operational at other DoD facilities, ensuring seamless integration without extensive and risky custom development.
Response and Challenge:
Interested parties who believe they can meet the requirements are invited to submit a statement of capabilities and qualifications. This statement must be submitted in writing to the contact person identified in this notice and must be received no later than the noted time and date.
The statement of capabilities must include:
Company name, address, point of contact, telephone number, and email address.
A detailed description of your company's capabilities to provide the specified requirement.
Evidence that your company meets all the requirements outlined in the "Description of Requirement" section.
Any other information that demonstrates your ability to perform the work.
A determination by the Defense Health Agency HCD-S not to compete this proposed contract action based upon responses to this notice is solely within the discretion of the HCD-S. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
This notice of intent is not a request for competitive proposals.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| Notice of Intent DNA Synthesizer | — | No set-aside | |
| 6640--Capillary Electrophoresis | Veterans Integrated Service Network 6 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| 6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ | Veterans Integrated Service Network 5 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity